Merck Swoops In On Buyout Bonanza With A $9.2 Billion Cidara Therapeutics Deal

investors.com/news/technology/cidara-therapeutics-stock-merck-takeover-branch

Cidara Therapeutics shares doubled, and then some, on Friday after Merck agreed to buy the biotech company for $9.2 billion.
The post Merck Swoops In On Buyout Bonanza With A $9.2 Billion Cidara Therapeutics Deal appeared first on Investor's Business Daily.

This story appeared on investors.com, 2025-11-14 14:55:15.
The Entire Business World on a Single Page. Free to Use →